linked

A New Era of Ownership

Source Node:
Time Stamp: March 12, 2024 6:15 AM - Modified On: March 12, 2024 - Published By:
Source Cluster:
Republished By Plato

Months ago, the mainstream media wrote articles about how crypto was dead and that there would never be another bull run. Wild predictions of Bitcoin going to zero sought to instill fear in people so they would turn away from the markets and invest in more traditional assets. Yet, despite the doomsday prophecies, Bitcoin has surged to new heights, defying expectations even before the halving takes place. The media has quickly forgotten its failed predictions and instead turned its attention to the NFT market, echoing similar skepticism. Several articles have

Lindsay Rosenwald’s Fortress Bio (NASDAQ: FBIO) Spotlight on 2024 Milestones from Subsidiaries

Source Node:
Time Stamp: February 2, 2024 2:30 PM - Modified On: February 2, 2024 - Published By:
Source Cluster:
Republished By Plato

  New York, Feb 2, 2024 - (Plato Data)- Fortress Biotech (Fortress Bio), a unique biotech company led by industry veteran Dr. Lindsay Rosenwald, focused on identifying, in-licensing and developing high-potential marketed drugs and development-stage drug candidates in-house and through its subsidiary partner companies, has announced multiple new milestones to start 2024 with a bang. Avenue Therapeutics Finalizes Phase 3 Study for IV Tramadol with FDA Avenue Therapeutics, a subsidiary of Fortress Bio, has reached a significant milestone in its quest to introduce new therapies for neurologic diseases. The company

NKGEN Biotech Received FDA Approval for Clinical Trials of SKN01 NK Cell Therapy in Alzheimer’s Disease Treatment.

Source Node:
Time Stamp: October 24, 2023 11:54 AM - Modified On: October 24, 2023 - Published By:
Source Cluster:
Republished By Plato

Summary: Progress in Neurodegenerative Research:  NKGen’s Phase 1/2a Clinical Trial for SNK01 on Track for End-of-Year Initiation SANTA ANA, Calif., Oct. 24, 2023 (Plato / Amplifi) -- Today, NKGen Biotech Inc. (Nasdaq: NKGN), a trailblazer in the field of autologous, allogeneic, and CAR-NK natural killer cell therapeutics, proudly announced the progression of its SNK01 program targeting Alzheimer’s Disease (AD), backed by the green light from the U.S. Food and Drug Administration (FDA) for its Investigational New Drug (IND) application. NKGen is gearing up to initiate its Phase 1/2a clinical trial

Cardiol Therapeutics (NASDAQ: CRDL) Advancements in Therapies for Inflammatory Heart Diseases

Source Node:
Time Stamp: October 13, 2023 5:16 AM - Modified On: October 13, 2023 - Published By:
Source Cluster:
Republished By Plato

In the United States, heart disease accounts for a significant number of deaths every year, with cardiovascular disease being the primary concern. Factors like lifestyle choices and unforeseen circumstances contribute to its prevalence. Myocarditis (inflammation of the heart muscle) and pericarditis (inflammation of the heart's lining) are two inflammatory heart conditions primarily linked to immunological reactions from viral infections and mRNA vaccines. Though considered rare, awareness of these conditions is growing, especially among younger populations. Recent research in Science Immunology highlighted an increase in cytokine production leading to myocarditis in

The Convergence of MedTech and Blockchain: Transforming Healthcare

Source Node:
Time Stamp: September 14, 2023 4:39 PM - Modified On: September 14, 2023 - Published By:
Source Cluster:
Republished By Plato

The healthcare industry has witnessed a remarkable transformation driven by technological advancements in recent years. One groundbreaking convergence is the fusion of Medical Technology (MedTech) and blockchain technology. This synergy has the potential to revolutionize healthcare by enhancing data security, interoperability, and patient-centric care. Enhanced Data Security: One of the foremost challenges in healthcare is ensuring the security and privacy of patient data. Medical records contain sensitive information that must be protected from unauthorized access and cyber threats. Blockchain technology offers a robust solution to this problem. Blockchain operates on

David Christopher Lee To Sell NFT Celebrity Portraits of Snoop Dogg and Lady Gaga, Which Will Be Linked to Exclusive Interactive Opportunities

Source Node:
Time Stamp: June 1, 2023 5:41 AM - Modified On: June 1, 2023 - Published By:
Source Cluster:
Republished By Plato

Lee’s Celebrity Portraits Will Kick Off the Launch of Illuminate, A Digital NFT Agency and Platform for Experienced Artists  June 1st, Los Angeles - Renowned photographer David Christopher Lee announced the sale of celebrity portraits of Lady Gaga and Snoop Dogg as digital collectibles on the newly launched Illuminate.art. Collectors will be able to purchase these NFTs on June 1st through Illuminate.art’s user-friendly platform, which accepts credit card or cryptocurrency. Throughout the month of June, David Christopher Lee will be partnering with Illuminate.art to sell other celebrity portraits as NFTs.

Ikonic Releases Esports NFT MarketPlace.

Source Node:
Time Stamp: August 22, 2022 9:53 AM - Modified On: August 22, 2022 - Published By:
Source Cluster:
Republished By Plato

Announcing the launch of IKONIC, the World’s First Dedicated NFT Platform for Esports and Gaming Collectibles. The IKONIC platform will be a full-service NFT marketplace that will serve pro-players, gamers, teams, and content creators within the gaming industry; a dedicated marketplace where they can create unique and rare digital items for their fans. IKONIC platform will launch on Monday, August 22nd, allowing esports players and gamers to create NFTs with their gameplay. The IKONIC team realized that some of the most amazing moments in gaming were vanishing just as fast